Schedule 13D ownership disclosure
Durata Therapeutics, Inc.
Security class unavailable · CUSIP: 26658A107
Event date: 2014-03-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,777,856
- Percent of class
- 6.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-14-020749
- Form type
- SC 13D
- Filer
- Durata Therapeutics, Inc.
- CIK
- CIK 1544116
- Filed
- Apr 04, 2014
- Reporting period
- Mar 21, 2014
- Description
- Schedule 13D beneficial ownership